Intelligence · Clinical pipeline
Metabolic & obesity · Phase III
Metabolic & obesity programs at Phase III — ClinicalTrials.gov pipeline intelligence.
Quick answer
Metabolic & obesity Phase III programs: NovaPharmaNews indexes 227 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- Takeda 35 programs
- NovoThirteen 25 programs
- Eli Lilly and 20 programs
- Regeneron UK 12 programs
- Boehringer Ingelheim 10 programs
- Novo Nordisk A/S 10 programs
- AstraZeneca 9 programs
- LEXICON PHARMACEUTICALS 8 programs
- Eli Lilly and 6 programs
- HOFFMANN-LA ROCHE 6 programs
- George Institute for 5 programs
- Kailera Therapeutics 5 programs
Pipeline programs
-
Tradipitant
Lacuna Pharma Pty Ltd
Idiopathic or diabetic gastroparesis with moderate to severe nausea.
1 trial -
Trelagliptin 25 mg
Takeda
Type 2 Diabetes Mellitus
1 trial -
Trichosanthes root
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetes Mellitus
1 trial -
Trulicity 0.75 mg solution for injection in pre-filled pen
The George Institute
Preventive treatment of post-kidney transplant diabetes
1 trial -
Trulicity 0.75 mg solution for injection in pre-filled pen
The George Institute
Metabolic syndrome in patients on the waiting list for kidney transplantation, Metabolic syndrome in patients on the waiting list for kidney transplantation
1 trial -
UDCA
The First People's Hospital of Lianyungang
Diabetes Mellitus
1 trial -
VEGF Trap-Eye (BAY86-5321)
Regeneron UK Limited
Diabetes Mellitus
1 trial -
VX-880
Vertex Pharmaceuticals (Australia) Pty.
Diabetes Mellitus, Type 1
1 trial -
VX-880 solution for infusion
Vertex Pharmaceuticals (Australia) Pty.
Type 1 Diabetes Mellitus with Impaired Hypoglycemic Awareness and Severe Hypoglycemia
1 trial -
Vildagliptin
Novartis Pharmaceuticals
Type 2 Diabetes Mellitus
1 trial -
Vildagliptin
Novartis Pharmaceuticals
Diabetes Mellitus, Type 2
1 trial -
WC45725
Hoffmann-La Roche
Obesity or Overweight Without Type 2 Diabetes
1 trial -
WC45726
Hoffmann-La Roche
Obesity or Overweight and Type 2 Diabetes
1 trial -
Wegovy solution for Diabetes Mellitus, Cardiovascul…
Istituto Gentili S.r.l.
Diabetes Mellitus, Cardiovascular disease, Overweight (BMI ≥27 kg/m²), Obesity (BMI≥30kg/m2)
1 trial -
aflibercept 8 mg PFS
Regeneron UK Limited
Diabetic Macular Edema (DME)
1 trial -
albiglutide + insulin glargine
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
biphasic insulin aspart
Novo Nordisk A/S
Diabetes
1 trial -
candesartan
Takeda
Type 2 Diabetes
1 trial -
candesartan
Takeda
Type 1 Diabetes
1 trial -
candesartan cilexetil
Takeda
Type 1 Diabetes
1 trial -
evogliptin
Dong Wang
Type 2 Diabetes Mellitus
1 trial -
exenatide once weekly
AstraZeneca
Type 2 Diabetes Mellitus
2 trials -
fluocinolone acetonide
ANI PHARMACEUTICALS INC
Diabetic Macular Edema
3 trials -
insulin degludec
Novo Nordisk A/S
Diabetes
2 trials -
linagliptine 5 mg
Boehringer Ingelheim
Diabetes Mellitus, Type 2
1 trial -
liraglutide
Novo Nordisk A/S
Diabetes
2 trials -
lixisenatide AVE0010
Sanofi Pasteur
Type 2 Diabetes Mellitus
1 trial -
lorcaserin
BRIGHT MINDS BIOSCIENCES INC.
Obesity
1 trial -
muraglitazar
Bristol-Myers Squibb
Diabetes Mellitus, Type 2
1 trial -
ofloxacin
ABEONA THERAPEUTICS INC.
Diabetic Foot Ulcers
2 trials -
pioglitazone
Hoffmann-La Roche
Diabetes Mellitus Type 2
1 trial -
placebo to match albiglutide
GlaxoSmithKline
Diabetes Mellitus, Type 2
1 trial -
rosiglitazone
Novo Nordisk A/S
Diabetes
1 trial -
semaglutide
Novo Nordisk A/S
Diabetes
4 trials -
survodutide
Boehringer Ingelheim
Obesity
1 trial
Frequently asked questions
How many metabolic & obesity Phase III programs exist?
227 programs match both the therapeutic area and stage filters in our published index.